KRAS and non-small cell lung carcinoma: Specifically, the primary aim of this study was to evaluate whether the survival rate of NSCLC patients with mKRAS G12C is similar to that of patients with tumors with either other KRAS mutations or KRAS-wild type (KRAS-WT).